<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Phys.org: Phys.Org news tagged with: gastric cancer</title>
<link>http://phys.org/</link>
<language>en-us</language> 
<description>Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Study discovers how cancer-causing bacterium spurs cell death</title>
   	 <description>Researchers report they have figured out how the cancer-causing bacterium Helicobacter pylori attacks a cell's energy infrastructure, sparking a series of events in the cell that ultimately lead it to self-destruct.</description>
     <link>http://phys.org/news239365986.html</link>
	 <category>Biology</category>
	 <pubDate>Tue, 01 Nov 2011 11:33:16 EST</pubDate>
	 <guid isPermaLink="false">news239365986</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2011/studydiscove.jpg" width="90" height="90" />
</item>
<item>
     <title>New fusion gene plays role in some stomach cancers</title>
   	 <description>A newly discovered hybrid gene appears to play a direct role in some stomach cancers, according to an international team of scientists led by researchers at Duke-NUS Graduate Medical School Singapore.</description>
     <link>http://phys.org/news221318805.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 06 Apr 2011 14:27:06 EST</pubDate>
	 <guid isPermaLink="false">news221318805</guid>
	 
</item>
<item>
     <title>Bad mix: Heavy beer drinking and a gene variant increases gastric cancer risk</title>
   	 <description>Heavy beer drinkers who have a specific genetic variant in the cluster of three genes that metabolize alcohol are at significantly higher risk of developing non-cardia gastric cancer, according to research presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.</description>
     <link>http://phys.org/news221134697.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 04 Apr 2011 11:18:32 EST</pubDate>
	 <guid isPermaLink="false">news221134697</guid>
	 
</item>
<item>
     <title>Detection of early gastric cancer using hydro-stomach CT</title>
   	 <description>A research team from South Korea evaluated the difference in diagnostic performance of hydro-stomach computed tomography (CT) to detect early gastric cancer (EGC) between blinded and nonblinded analysis and to assess independent factors affecting visibility of cancer foci. They found that the diagnostic performance of hydrostomach CT to detect an EGC was not significantly different between blinded and nonblinded analysis. The tumor size and invasion depth were independent factors for visibility.</description>
     <link>http://phys.org/news219402273.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 15 Mar 2011 10:05:11 EST</pubDate>
	 <guid isPermaLink="false">news219402273</guid>
	 
</item>
<item>
     <title>Urinary metabolomic profile and gastric cancer</title>
   	 <description>A research team from China investigated urinary metabolites expression changes among three mice groups using gas chromatography/mass spectrometry. Ten metabolites have differences between the normal group and the cancer group (non-metastasis group and metastasis group). Furthermore, seven metabolites with characteristic expression levels were identified between non-metastasis group and metastasis group.</description>
     <link>http://phys.org/news218800403.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 08 Mar 2011 11:00:01 EST</pubDate>
	 <guid isPermaLink="false">news218800403</guid>
	 
</item>
<item>
     <title>T-regulatory lymphocytes in gastrointestinal cancer</title>
   	 <description>A research team from Poland and United Kingdom assessed the absolute number of T-regulatory cells in the peripheral blood of gastric and colorectal cancer patients. The study showed the absolute number of Tregs in the peripheral blood of gastric cancer patients was significantly decreased in comparison to that in the healthy controls.</description>
     <link>http://phys.org/news215690905.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 31 Jan 2011 10:08:48 EST</pubDate>
	 <guid isPermaLink="false">news215690905</guid>
	 
</item>
<item>
     <title>Remote-controlled capsule endoscope safely examines the stomach</title>
   	 <description>A study from researchers in Germany showed that magnetic maneuvering of a modified capsule endoscope in the stomach of healthy volunteers under clinical conditions is safe, well-tolerated, and technically feasible. Maneuverability of the capsule within the stomach was excellent and visualization of the gastric mucosa, the inner lining of the stomach, was satisfactory in the majority of subjects. Apart from a single experiment performed with a supervising flexible gastroscope, this was the first study to use the system in the stomach of healthy subjects. The study appears in the January issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE).</description>
     <link>http://phys.org/news214573597.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 18 Jan 2011 12:10:03 EST</pubDate>
	 <guid isPermaLink="false">news214573597</guid>
	 
</item>
<item>
     <title>Effects of chemoradiation therapy by using capecitabine on gastric cancer patients</title>
   	 <description>A research team from Singapore reviewed the outcome of patients with resected gastric cancers treated with capecitabine and radiation compared to 5-fluorouracil with radiation or fluoropyrimidine-based chemotherapy only. They found that survival of patients treated with capecitabine and radiation was comparable to the other two conventional treatments</description>
     <link>http://phys.org/news204200642.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 20 Sep 2010 13:30:01 EST</pubDate>
	 <guid isPermaLink="false">news204200642</guid>
	 
</item>
<item>
     <title>Addition of trastuzumab to chemotherapy for stomach cancer extends survival by nearly 3 months</title>
   	 <description>An Article published Online First by The Lancet says that for patients with HER2-positive advanced gastric cancer, addition of tastuzumab to standard cisplatinum/fluoropyrimidine chemotherapy results in a median survival of 13.8 months, compared with 11.1 months with chemotherapy alone. This corresponds to a 26% reduction in the death rate for patients in the trastuzumab group. Thus trastuzumab combined with standard chemotherapy could be considered a new standard option for patients with this condition. However, an accompanying Comment questions the cost effectiveness of the treatment. The Article is by Professor Yung-Jue Bang, Seoul National University College of Medicine, Seoul, South Korea, and Dr Eric van Custem, University Hospital Gathuisberg, Leuven, Belgium, and colleagues.</description>
     <link>http://phys.org/news201461667.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 19 Aug 2010 18:34:41 EST</pubDate>
	 <guid isPermaLink="false">news201461667</guid>
	 
</item>
<item>
     <title>Drugs used to treat osteoporosis not linked with higher risk of esophageal cancer</title>
   	 <description>Although some reports have suggested a link between the use of oral bisphosphonates (drugs that prevent the loss of bone mass) and esophageal cancer, analysis of medical data from more than 80,000 patients in the United Kingdom found that use of these drugs was not significantly associated with new cases of esophageal or gastric cancer, according to a study in the August 11 issue of JAMA.</description>
     <link>http://phys.org/news200669975.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 10 Aug 2010 16:10:04 EST</pubDate>
	 <guid isPermaLink="false">news200669975</guid>
	 
</item>
<item>
     <title>Cancer-causing bacterium targets tumor-suppressor protein</title>
   	 <description>Researchers have discovered a mechanism by which Helicobacter pylori, the only known cancer-causing bacterium, disables a tumor suppressor protein in host cells.</description>
     <link>http://phys.org/news199892547.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 02 Aug 2010 06:00:01 EST</pubDate>
	 <guid isPermaLink="false">news199892547</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/cancercausin.jpg" width="90" height="90" />
</item>
<item>
     <title>How to detect malnutrition in patients effectively?</title>
   	 <description>Malnutrition is a common problem in patients with cancer and is associated with a poor outcome. The assessment of nutritional status and its evaluation plays an important role in tailoring nutritional support. A study from South Korea evaluates the relationships between objective and subjective nutritional assessment of gastric cancer patients and suggests that a specific tailored nutritional assessment is needed for accurate measurement of the nutritional status of gastric cancer patients.</description>
     <link>http://phys.org/news199705508.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 30 Jul 2010 12:20:01 EST</pubDate>
	 <guid isPermaLink="false">news199705508</guid>
	 
</item>
<item>
     <title>Fox Chase clinical trial tests first of its kind antibody</title>
   	 <description>Patients with HER2-positive cancers can have dramatic responses to HER2-targeted drugs but eventually develop resistance to the agents. With that problem in mind, Fox Chase Cancer Center researchers are testing a novel type of antibody called MM-111 in patients with HER2-positive disease who have progressed on standard therapy.</description>
     <link>http://phys.org/news194876583.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 04 Jun 2010 13:40:01 EST</pubDate>
	 <guid isPermaLink="false">news194876583</guid>
	 
</item>
<item>
     <title>Shape matters: The corkscrew twist of H. pylori enables it to 'set up shop' in the stomach</title>
   	 <description>The bacterium Helicobacter pylori, which lives in the human stomach and is associated with ulcers and gastric cancer, is shaped like a corkscrew, or helix. For years researchers have hypothesized that the bacterium's twisty shape is what enables it to survive - and thrive - within the stomach's acid-drenched environment, but until now they have had no proof.</description>
     <link>http://phys.org/news194181538.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 27 May 2010 12:19:26 EST</pubDate>
	 <guid isPermaLink="false">news194181538</guid>
	 
</item>
<item>
     <title>Can eGFR be a routine preoperative renal function test?</title>
   	 <description>A research team from Japan evaluated the validity of the estimated glomerular filtration rate (eGFR) as a preoperative renal function parameter in patients with gastric cancer. Their study showed that eGFR was as equally reliable as creatinine clearance for assessment of preoperative renal function in patients with gastric cancer.</description>
     <link>http://phys.org/news193572658.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 20 May 2010 11:20:01 EST</pubDate>
	 <guid isPermaLink="false">news193572658</guid>
	 
</item>
<item>
     <title>Study examines incidence of gastric cancer</title>
   	 <description>The incidence of a certain type of gastric cancer has declined in the last 30 years for all age groups and races, except for whites 25 to 39 years of age, according to a study in the May 5 issue of JAMA.</description>
     <link>http://phys.org/news192211103.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 04 May 2010 17:50:06 EST</pubDate>
	 <guid isPermaLink="false">news192211103</guid>
	 
</item>
<item>
     <title>Chemotherapy after gastric cancer surgery appears to provide survival benefit</title>
   	 <description>Patients who have gastric cancer surgery followed by chemotherapy have an associated decreased risk of death and improved disease-free survival compared to patients who have surgery alone, according to an analysis of previous studies, reported in the May 5 issue of JAMA.</description>
     <link>http://phys.org/news192210809.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 04 May 2010 17:30:01 EST</pubDate>
	 <guid isPermaLink="false">news192210809</guid>
	 
</item>
<item>
     <title>Study offers first clinical evidence of anti-cancer drug triggering viral infection</title>
   	 <description>Important advances in the fight against cancer have come as researchers proved that viruses and cancers interact in ways that were previously unknown to scientists.</description>
     <link>http://phys.org/news190308154.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 12 Apr 2010 17:00:02 EST</pubDate>
	 <guid isPermaLink="false">news190308154</guid>
	 
</item>
<item>
     <title>Factors increasing the risk of atrophic gastritis and intestinal metaplasia</title>
   	 <description>Atrophic gastritis and intestinal metaplasia are two important precursory lesions in the process of intestinal type gastric cancer.  However, the precise mechanism of the progression of these two lesions is still unclear, a few studies have investigated the risk of host gene polymorphism on the atrophic gastritis and intestinal metaplasia, but all of them are limited by their one-time point screen.</description>
     <link>http://phys.org/news190289377.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 12 Apr 2010 12:10:01 EST</pubDate>
	 <guid isPermaLink="false">news190289377</guid>
	 
</item>
<item>
     <title>Exploring the 'Davids and Goliaths' of therapeutic molecules</title>
   	 <description>Two research units under Singapore's Agency for Science, Technology and Research (A*STAR), the Experimental Therapeutics Centre (ETC) and Singapore Immunology Network (SIgN), are collaborating with Italy's Siena Biotech S.p.A. to develop new drugs and targeted antibodies respectively, which will potentially help millions of cancer and bone loss patients across the world.  This is the fifth major collaboration A*STAR has with research centres and universities in Italy.</description>
     <link>http://phys.org/news189943013.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 08 Apr 2010 11:44:27 EST</pubDate>
	 <guid isPermaLink="false">news189943013</guid>
	 
</item>
<item>
     <title>Expression of gelatinases in gastric cancer and superficial gastritis</title>
   	 <description>A research team in Mexico, led by Dr. Clara Luz Sampieri from the Institute of Public Health of Veracruzana University investigated genetic expression of MMP2 and MMP9 in gastric tumor and gastritis tissues using a population from Mexico. They observed a significantly increased expression of MMP9 in tumor tissues, but not in superficial gastritis.</description>
     <link>http://phys.org/news189940346.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 08 Apr 2010 10:12:46 EST</pubDate>
	 <guid isPermaLink="false">news189940346</guid>
	 
</item>
<item>
     <title>Promising hormone may help reduce malnutrition in gastric cancer patients</title>
   	 <description>In gastric cancer patients who have had part or all of their stomach removed, the hormone ghrelin may lessen post-operative weight loss and improve appetite, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.</description>
     <link>http://phys.org/news189257214.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 31 Mar 2010 12:27:20 EST</pubDate>
	 <guid isPermaLink="false">news189257214</guid>
	 
</item>
<item>
     <title>Preventing gastric cancer with antibiotics</title>
   	 <description>Helicobacter pylori, a bacterium found in about 50% of humans worldwide, can cause stomach ulcers and, in extreme cases, gastric cancer. In an article for F1000 Medicine Reports, Seiji Shiota and Yoshio Yamaoka discuss the possible eradication of H. pylori infections</description>
     <link>http://phys.org/news187608287.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 12 Mar 2010 10:10:01 EST</pubDate>
	 <guid isPermaLink="false">news187608287</guid>
	 
</item>
<item>
     <title>Perceived health can predict survival of esophago-gastric cancer</title>
   	 <description>(PhysOrg.com) -- Changes in patients' self-rated quality of life after treatment for esophago-gastric cancer can predict the chances for long-term survival. This is the result researchers at the Swedish medical university Karolinska Institutet made, in a new study published in the Journal of Clinical Oncology.</description>
     <link>http://phys.org/news187383793.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 09 Mar 2010 19:30:06 EST</pubDate>
	 <guid isPermaLink="false">news187383793</guid>
	 
</item>
<item>
     <title>Herceptin and Tykerb effective against a subset of gastric cancers</title>
   	 <description>A combination of two targeted therapies already shown to be effective in breast cancer packs an effective one-two punch against a subset of gastric cancers that have a specific genetic mutation, a study at UCLA's Jonsson Comprehensive Cancer Center has found.</description>
     <link>http://phys.org/news186829559.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 03 Mar 2010 09:06:11 EST</pubDate>
	 <guid isPermaLink="false">news186829559</guid>
	 
</item>
<item>
     <title>Helicobacter pylori and EBV in gastric carcinomas</title>
   	 <description>Mechanisms of gastric carcinogenesis are still not yet understood. Studies have linked genetic and epigenetic factors or microbiological agents to gastric cancer, but they didn't look for these events together. Dr. Ferrasi from Brazil verified the methylation profile, microsatellite instability (MSI), Helicobacter pylori status and Epstein Barr virus infection in gastric cancer samples. Intestinal and diffuse adenocarcinoma showed different methylation profiles and an association was found between methylation and Helicobacter pylori-cagA+.</description>
     <link>http://phys.org/news184963044.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 10 Feb 2010 01:10:02 EST</pubDate>
	 <guid isPermaLink="false">news184963044</guid>
	 
</item>
<item>
     <title>New finding of the expression of Helicobacter pylori in Chilean patients</title>
   	 <description>Helicobacter pylori (H. pylori) colonize the human stomach and present genetic mechanisms to evade the host immune response allowing their persistence in this habitat for years. A study involving 130 H. pylori strains isolated from patients living in different Chilean cities revealed that, nearly half of them carry the hopE and hopV genes. The results suggest that these genes can be turned on and off, and are likely to be involved in avoiding immune recognition.</description>
     <link>http://phys.org/news184959168.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 09 Feb 2010 23:10:01 EST</pubDate>
	 <guid isPermaLink="false">news184959168</guid>
	 
</item>
<item>
     <title>Which intestinal metapasia is closer with gastric cancer? Simple or atypical?</title>
   	 <description>The classification of intestinal metapasia (IM) is confusing. A research group in China observed IM in gastric biopsies and divided IM into simple IM (SIM) and atypical IM (AIM). By detecting three tumor-associated proteins, p53, c-erbB-2 and Ki67, in IM and gastric cancer, they compared two types of classification in intestinal metaplasia. They found that AIM may have a much more close relationship with gastric cancer.</description>
     <link>http://phys.org/news184959105.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 09 Feb 2010 20:40:01 EST</pubDate>
	 <guid isPermaLink="false">news184959105</guid>
	 
</item>
<item>
     <title>Characteristics of young age gastric cancer patients</title>
   	 <description>Two percent to fifteen percent of patients with gastric cancer (GC) are younger than 45 years of age and there has been an increase in the relative proportion of young age GC compared with older age GC, especially in young females. The question of whether young age GC is different from that of older patients has been raised but remains unresolved.</description>
     <link>http://phys.org/news183117685.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 19 Jan 2010 10:01:37 EST</pubDate>
	 <guid isPermaLink="false">news183117685</guid>
	 
</item>
<item>
     <title>Team finds link between stomach-cancer bug and cancer-promoting factor</title>
   	 <description>Researchers report that Helicobacter pylori, the only bacterium known to survive in the harsh environment of the human stomach, directly activates an enzyme in host cells that has been associated with several types of cancer, including gastric cancer.</description>
     <link>http://phys.org/news182001373.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 06 Jan 2010 11:56:47 EST</pubDate>
	 <guid isPermaLink="false">news182001373</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/teamfindslin.jpg" width="90" height="72" />
</item>


</channel>
</rss>
